Pfizer’s Bold Bet on Liquid Biopsies: Can It Spark a Turnaround?
Liquid biopsy technology emerges as a groundbreaking tool in cancer diagnostics, enabling early and accurate detection through blood tests. Pfizer's collaboration with Guardant Health aims to enhance its oncology portfolio,…